Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.44 USD | -1.43% | -5.79% | +101.18% |
04-25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | North American Morning Briefing : Stock Futures -2- | DJ |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 06-09-30 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 21-05-09 |
Sharon Perry
LAW | General Counsel | - | 07-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 17-02-15 |
Robert Conway
CHM | Chairman | 70 | 13-09-02 |
Linda Grais
BRD | Director/Board Member | 68 | 07-04-30 |
Jacob Ma-Weaver
BRD | Director/Board Member | 37 | 22-06-14 |
James Flynn
BRD | Director/Board Member | 43 | 22-12-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,507,143 | 14,320,024 ( 98.71 %) | 0 | 98.71 % |
Company contact information
ARCA biopharma, Inc.
10170 Church Ranch Way Suite 100
80021, Westminster
+720 940 2200
http://www.arcabio.comSector
1st Jan change | Capi. | |
---|---|---|
+101.18% | 50.61M | |
-2.59% | 102B | |
+2.23% | 96.09B | |
+2.13% | 22.28B | |
-17.09% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.90% | 16.09B | |
+6.51% | 13.83B | |
+32.26% | 11.97B |
- Stock Market
- Equities
- ABIO Stock
- Company ARCA biopharma, Inc.